Kuhlmann Shirley R.'s Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Jun 28, 2023
- Accession no.
- 0001062993-23-014095
- Filed
- Jun 28, 2023
- Trade date
- Jun 26, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $390.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kuhlmann Shirley R.CIK 0001734919 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | Common Stock | SSaleDisposed | −16,621 | $21.65 | −$359,844.65 | 120,881 | Direct | |
| Jun 26, 2023 | Common Stock | SSaleDisposed | −1,363 | $22.53 | −$30,708.39 | 119,518 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.